文献速递牙体牙髓病

生物陶瓷封闭剂iRoot SP通过miR-141-3p/SPAG9/MAPK通路促进根尖乳头干细胞成骨分化

The bioceramic sealer iRoot SP promotes osteogenic differentiation of human stem cells from apical papilla via miR-141-3p/SPAG9/MAPK signalling pathway.
PubMed 文献 · Int Endod J · 2023-08-02

该体外研究探讨iRoot SP处理的人根尖乳头干细胞(hSCAPs)中miR-141-3p在成骨分化中的作用及机制。结果显示iRoot SP下调miR-141-3p,进而负调控SPAG9/MAPK信号轴,促进成骨标志物表达。结论提示iRoot SP可能通过该通路诱导难治性根尖周炎的骨再生。

要点

  • iRoot SP可下调hSCAPs中miR-141-3p并促进成骨分化。
  • miR-141-3p负调控SPAG9/MAPK信号轴。
  • 该机制为iRoot SP促进根尖周骨再生提供依据。

核心结论

  • iRoot SP通过抑制miR-141-3p、下调SPAG9并激活MAPK通路促进hSCAPs成骨分化,提示其可能诱导难治性根尖周炎骨再生。

研究设计与样本

  • 体外实验:酶消化法提取hSCAPs,经免疫荧光、流式细胞术和茜素红染色鉴定。

主要发现

  • iRoot SP处理hSCAPs后miR-141-3p表达随暴露时间延长至7天而降低。
  • 成骨标志物OCN、OSX、RUNX2和DSPP与miR-141-3p表达呈负相关。
  • 双荧光素酶报告实验证实SPAG9为miR-141-3p下游靶基因。
  • 体外实验验证miR-141-3p与SPAG9/MAPK信号轴存在负调控关系。

关键数值与推荐

  • 使用ALP染色与活性检测、茜素红染色、钙浓度测定、qRT-PCR和western blot评估成骨分化。
  • 数据采用单因素方差分析和Tukey事后检验,p < .05认为有统计学意义。

临床怎么用

  • 提示iRoot SP除抗菌外可能通过miR-141-3p/SPAG9/MAPK通路促进根尖周骨再生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The premixed bioceramic sealer iRoot SP that is widely used clinically has been reported to kill bacterial biofilms and promote osteogenic differentiation of human stem cells from the apical papilla (hSCAPs). Although miR-141-3p has been substantiated to be involved in the osteogenic process, the underlying mechanisms remain unclear. The aim of this study was to investigate the role of miR-141-3p in osteogenic differentiation and underlying mechanisms of iRoot SP-treated hSCAPs. METHODOLOGY: hSCAPs were extracted from tissue blocks with enzyme digestion and identified by using immunofluorescence, flow cytometry and alizarin red staining. The mRNA expression level of miR-141-3p in hSCPAs after culture with iRoot SP was examined by quantitative real-time PCR (qRT-PCR) assay. SPAG9 was identified as a downstream target gene of miR-141-3p by dual-luciferase report assay. Alkaline phosphatase (ALP) staining and activity detection, alizarin red staining, calcium concentration assay, qRT-PCR and western blot were used to estimate osteogenic differentiation ability and involved protein expression levels of the osteogenic makers and signalling pathway-related factors in iRoot SP-treated hSCAPs. Data were analysed by one-way anova and post hoc Tukey's test to determine any statistical differences between the experimental groups and the control group. p < .05 was considered statistically significant. RESULTS: Expression of miR-141-3p was reduced in iRoot SP-treated hSCAPs with the increased exposure time up to 7 days, and the western blot and qRT-PCR results revealed that the osteogenic markers osteocalcin (OCN), osterix (OSX), runt-related transcription factor 2 (RUNX2) and dentin sialophosphoprotein (DSPP) were inversely correlated with miR-141-3p. The negative regulatory relationship between miR-141-3p and SPAG9/ mitogen-activated protein kinases (MAPK) signalling axis was validated in this in vitro experiments. CONCLUSIONS: The bioceramic sealer iRoot SP promoted osteogenic differentiation of hSCAPs by inhibiting miR-141-3p following down-regulated SPAG9 expression, and activated MAPK pathway. These findings proposed a novel therapeutic impact of bioceramic sealer iRoot SP inducing bone regeneration in refractory periapical periodontitis.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Xue K, Hu G, Wu L, et al. The bioceramic sealer iRoot SP promotes osteogenic differentiation of human stem cells from apical papilla via miR-141-3p/SPAG9/MAPK signalling pathway. Int Endod J. 2023. PMID: 37357722. doi:10.1111/iej.13948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。